michelcarroll/llama2-earnings-stock-prediction-fine-tune huggingface dataset:
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Again, we are working with the FDA. We have submitted the IDE -- pardon me, too many acronyms. We've submitted the PMA supplement with the DMC recommendation. So far, so good.
We're interacting with the FDA. There are a variety of outcomes possible. And we will -- when we have the final determination from the FDA, we'll make that information available to everyone.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. We haven't shared that specific number. We've given you the impact on how to adjust for the quarter of our volume that is Medicare pricing. So I'll let you do them after 25% Medicare pricing -- price went from 311 gross to 115 gross I mean that will get you in the ballpark of how to translate this, the magnitude of the revenue growth into closer to a volume growth. And I mean obviously Zio AT has grown significantly and you are correct that Zio AT particularly with the decline in Zio XT pricing is -- it's more than 2x the Zio XT price at this point.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi, Michael. I can probably take that one, it's Stephen. I think it's fair to say there's a lot learned from the scenario that we're going through at the moment. I mean, we've talked at length about the pandemic.
And it's quite clear that it impacted us to certain extent when it comes to testing and tweaking a game toward the end of a project, more so than we would have liked. And that's one of the reasons why we've extended the timeline, because as our different studios around the world, including the test teams and we are dotted all over this planet. At times, local restrictions have meant that people have had to relocate to work from home and contribute from home that does cause particular challenges for us. If we've learned one thing from this process, it's probably how to work effectively in a very fast-changing and dynamic environment.
We can't predict rules that occur around the world. And moving specific hardware from the office to home has been a technical challenge not only for us, but our partners in Sony and Microsoft and we've learned a lot from those relationships. So I think it's important to understand the ever changing dynamic that we have to address and also this kind of period of extension if I can just address this as given us the opportunity to leverage the input of recent superstars that have been joining most sport games. And their input into the product, I think has been quite significant, which improves the quality of the end game, and also rolls into subsequent products from multiple games.
So there's a lot to learn. And there are positives to take on this as well.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi, everyone. And first of all, congratulations for the results. I would like to know if you can give us a little bit more color on your expectation for the second half of 2020, like you think the earnings is going to be -- are going to behave the same as the first half of the year? And also, I would like to know if you can give us a little bit more color about what are your expectations on loan growth. Like if you can give us like the consumption, the consumer, the market segments, how they will grow if you have the detail. Thank you.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Hi, Vince, and good to have you on the call here today. Certainly, our -- we've always been more efficient with transaction capital on our renewal leases than new leases. And that has not changed in 2020. We haven't broken that out in anything that we've released to date, but I can tell you that -- and I'm just looking at the stats here. We're roughly around $1 a square foot -- call it, $1.11 per square foot on transaction costs on our renewal leases, in -- that were for renewals that were signed in the fourth quarter. So hopefully, that gives you some context in terms of the difference between the efficiency we've been able to achieve on the renewals versus new leases.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Lucas, thank you. Good to hear your voice. To give you the most confidence in the first questions, I'll let Murray take them and then I'll see if I can help on the hub question.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Thanks, Matt. I appreciate the question. It's a bit of all of the things that you just mentioned. We're bringing in, clearly, we had a bit of a pent-up demand that's opened up, and we saw double-digit growth comparative sequentially quarter-to-quarter and the number of surgeons trained. So all things considered, we're ramping up our ability to train on Simplify, I think that's garnering interest in the portfolio. We continue now to reestablish the focus we had with X360 pre pandemic. So all in all, just probably both pent-up demand and just the normal training that we've traditionally done. So it's a little bit of everything.
I think the broader portfolio is attracting a new subset of surgeons to our campus that likely hasn't been there in the past, specifically in the fact that we didn't have certain aspects and we talk about multiple vectors of growth, we think that will continue. Obviously, we talked a little bit about the experience center on the East Coast. We think that also expands our reach. So that's still in our future. But all in all, positive signs, positive indicators that the market is returning with the number of people we're seeing come through in training.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Certainly, good question, Ken. And as it relates to Intermodal, in the East, we are back to reliability that's prepandemic, so performing very, very well. As I mentioned in my opening thoughts, four or five quarters now where we've grown in the mid-double-digit range in the East, and that continues to be a real area of strength across our network because of our dray performance, but also we have a rail partner that's performing very, very well there.
The West is improving, still not back to, I think, where anybody would be satisfied, but at least showing signs of improvement. But there's just a lot of other constraints going on there relative to the port activity, customer delays of getting equipment turned. And so it's a little more challenging in the West than it's proven to be in the East, but improving.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks, Esther.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I'll defer that to Matias as he's part of...

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. During the fourth quarter -- that is correct. So, we feel good about where -- if you look at the comp basis, the quarter to date 10.5% is a really strong number. And that includes the Halloween weekend, which is traditionally not that great of a sales period, so.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
No. The commodity and ingredient would be the leading factor. 

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. I'm trying to be cautious on this because, as we know, things change pretty -- it can change pretty quickly. So I think --

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, again, h&h and Nestle, as well as row, the new announcement that we made and life extension, the other company. This is all we have always said that on a selective basis, we will supply nitrogen as an ingredient to certain companies that we consider to be responsible companies, excellent companies, blue chip companies that have an existing customer base, as opposed to using our ingredient to create a customer base. And in all, in all cases, we endeavor to co brand if possible. Nestle obviously is the world's leading food company. They released sell trient, as a product is over. It's a very slow and gradual release. It's the way they go about doing it.
Step by step process. It's initially simply just an online distribution channel. But there are other divisions within Nestle that are interesting to us as well, including persona, which we started doing business with persona last year. This is a personalized dietary supplement division that they own. There are other divisions at Nestle with whom we are also having conversations and at some point, we might expand the relationship to include some of these other divisions, in addition to celltrion and persona. So we're not surprised because we always anticipated that celltrion would be a slow rollout. It we expect it to grow with time and but we expect the relationship with Nestle in time to expand to go beyond simply just celltrion.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks, Jacob.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Ralph, so no. And actually, what I would say is we actually -- commercial has been way ahead of CMS on this for a long time, right? We were doing commercial joints. We were doing commercial procedures long before this, we've got a great safety track record. I mean the commercial payers are quite bullish on trying to push into our setting, whether that's through pre-authorizations or other things.
And honestly, I think that that momentum -- nothing is going to change that. It's such a value proposition for them. And increasingly, in fact, I think they're going to push faster. I don't think this has any impact on the commercial side of the business.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Think about that, 30 or 50.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Tarek, you want to talk about the -- 

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Actually, I might defer to Bob on that question. That's all right. Bob?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you. So on cost, yes, I suggest you wait till February to address that in terms of the Ulster position. On NatWest markets, I mean in terms of how it's performing. I think we're still seeing a very strong performance in our currencies and capital markets business.
I think we've -- in terms of October, there's no real change to the trends we're seeing in Q3. So continued weakness in the fixed income performance in Q4 as we finish the reshaping of that business. I think that's what I'd say. But both our currencies, capital markets are performing well.
Our sort of pipeline in terms of syndicated lending and corporate remains very strong. So that is continuing to Q4, but you'll still see weakness in the fixed income business. NIM, Katie? 

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure. So we'll talk a bit about that at Investor Day in terms of how we're thinking about the international market and sort of what the end state is and what the footprint should look like. What I will say is that the -- our international investments we're doing this on a rolling basis, as I indicated, three countries are behind us and three countries are now on the dock. And lots of -- I think there's -- the markets internationally are very robust. The veterinary practices are also busy. And we know that from the standpoint of best or most optimized loading, we're still far off from where we are in the U.S. just by way of benchmark where we have about 120 accounts or so per account manager internationally, it's a lot less. So we think that the investments internationally offer a really good return. There's a lot of -- I think there's a lot of market development still before us. And again, we'll provide a little more specific meat and bone when we meet in a couple of weeks.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. I'll start out with the broader question and then let Gary fill in on some of the specifics. But if you look at the commitment on doubling the business digitally and the continued improvement in profitability, we would expect -- we continue to expect those broader trends to hold in place. Everything that we can see, the customers continue to like to shop online.
The thing that I think is very important is that very few of our customers actually only shop online, and most shoppers shop online and in our stores. And when they shop, both our retention rate is incredibly high and our ability to gain share within that household is very high as well. And those are the major trends that we would expect to continue and those are the trends that we believe that will drive our ability to double our online business, along with expanding with the sheds and other pieces. In terms of -- if you look at within the year, Gary, I'll let you talk through that.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Great. Thank you, everybody, for joining us today. We hope you have a great holiday weekend. 

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you very much for the question, Stephanie. You know, so we acquired RxSaver on April 30th for $50 million in cash. RxSaver shares our mission of helping Americans get the healthcare they need, price they can afford, is passionate about making healthcare more convenient, accessible, affordable. You know, the RxSaver acquisition allows us to extend our reach and prescription transactions by adding a small consumer base and a brand that's known and resonates with a subset of consumers.
The company has a talented team and knows the prescription transaction space well. We think they'll be highly complementary to GoodRx. We do -– to your sort of latter part of the question, we intend to keep the brand and believe there are some marketing channels and such that they have used that are potentially things that will be helpful broadly for GoodRx. We are excited to welcome the RxSaver team to GoodRx.
Relative to [Inaudible] filled, any change would be immaterial. With their businesses, it is relatively small here, but I'd say -– speaking to philosophy, I think it varies. We've had a series of acquisitions we've done, all of which have been quite successful. Whether we keep the brand, keep the -– integrate the teams is pretty specific to the transaction itself and what works fast.
And in this case, we will keep the brand as separate, but we will integrate sort of teams since these are really, really complementary, but it varies in different cases.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes, that's the way we designers that we can scale into a market cheaper with the way we're going to market now.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Last question please.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Okay. And we're working -- OK. We're coming up with better measurement systems, Josh, as far as being able to identify if we're actually making a better penetration. Looking at attachment rates on equipment, looking at normal business cycles, looking at warranty rates and warranty population against what the industry has out there. So we're doing an awful lot of analytic work on this to be able to measure and determine how we can continue to grow in that area.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I'm sorry can you repeat the question? I know it's UK-related.

    Prediction (one of UP, DOWN, SAME): SAME